BILL · 2005–06 SESSION
SB 6462: Biotechnology product
Providing biotechnology product and medical device manufacturing tax incentives.
Summary
- State and local sales and use taxes are deferred for investments in construction or renovation of structure, or machinery and equipment, used for biotechnology product or medical device manufacturing. The deferred taxes need not be repaid unless the property is used for ineligible purposes.
From the Senate Bill Report (SB 6462), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 12, 2006
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Paull Shin (D-21)
- Introduced
- January 12, 2006 in the Senate
- Last action
- February 2, 2006
- Companion bill
- HB 2640
- Budget
- Has a fiscal note
AN ACT Relating to biotechnology product and medical device manufacturing tax incentives;
Sponsors
Prime sponsor: Paull Shin (D-21)
8 co-sponsors (4 Democrats, 4 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- Referred to Ways & Means.
- And refer to Ways & Means.
- ITED - Majority; do pass.
- First reading, referred to International Trade & Economic Development.
SB 6462 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6462 (2019–20) Local income taxes
- SB 6462 (2017–18) Oil tank insur. disclosure
- SB 6462 (2015–16) Leasehold excise tax credit
- SB 6462 (2013–14) Health care/volunteers
- SB 6462 (2011–12) Public assistnce eligibility
- SB 6462 (2009–10) Firefighter duties/wildfire
- SB 6462 (2007–08) Housing bond proceeds
- SB 6462 (2003–04) Betting limits